Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8767579 | 0.96 | PKM (0.40) | PKMLMNAHTTMEN1KMT2A | |
| SCHEMBL8772395 | 0.84 | LMNA (0.39) | PKMLMNAHTTMEN1KMT2A | |
| SCHEMBL8766787 | 0.84 | HTT (0.39) | LMNAHTTMEN1KMT2AADRA1D | |
| SCHEMBL8767339 | 0.76 | HTT (0.38) | PKMLMNAHTTMEN1KMT2A | |
| SCHEMBL8767314 | 0.75 | PKM (0.38) | PKMLMNAHTTMEN1KMT2A | |
| SCHEMBL8766468 | 0.74 | PKM (0.41) | PKMLMNAHTTADRA1DADRA1A | |
| SCHEMBL8767549 | 0.72 | LMNA (0.39) | LMNA | |
| SCHEMBL8766856 | 0.71 | HTT (0.39) | LMNAHTTMEN1KMT2AADRA1D | |
| SCHEMBL8766792 | 0.70 | TRPA1 (0.40) | LMNA | |
| SCHEMBL8553752 | 0.69 | CACNA2D1 (0.40) | PKMLMNAHTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0788478-A1 | AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS | SMITHKLINE BEECHAM PLC (GB) | 1997-08-13 | — | — | EP | claimed |